NCT00160979View on ClinicalTrials.gov

Transrectal Tumour Oxygen - US Army

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Prostatic Neoplasms
Interventions
PROCEDURE

Pre-treatment tumour oxygen measurements

Pre-treatment tumour oxygen measurements

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00160979 - Transrectal Tumour Oxygen - US Army | Biotech Hunter | Biotech Hunter